Singapore promotes biomedical and population health development at the national strategic level
China announced its “Made in China 2025” manufacturing strategy in May 2015, which places the biomedical and high-performing medical instruments sector as one of China’s pillar industries. China could draw lessons from Singapore’s experience over the last decade, when the Singapore government began investing substantially in biomedical research since 2000. 10 years on, Singapore hasRead more










